Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Day of Rage Planned in Vancouver to ‘Reject Zionist Annexation of Palestinian Land’

Several student groups at the University of British Columbia…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

IDF Preparing for Battle, Strikes Hamas Targets Throughout the Gaza Strip

In response to three days of incendiary balloon attacks from…
Read more

China Sends Astronauts to Self-Developed Space Station

On Thursday China sent their first group of astronauts to…
Read more